Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipid profiles after switching from efavirenz to dolutegravir in HIV-infected patients with dyslipidemia
TCTR20221118002Unknown
- Sponsor
- Khon Kaen University
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-arm trial of dolutegravir in human immunodeficiency virus infection (HIV) and dyslipidemia, sponsored by Khon Kaen University. Primary endpoint: Change in lipid profile after switching to dolutegravir. Status: unknown.
02
Drugs
dolutegravir
03
Conditions
human immunodeficiency virus infection (HIV)dyslipidemia
Beyond the preview
Go deeper on TCTR20221118002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221118002.